Neurothrombectomy Devices Market 2021-2026: Size, Share, Industry Analysis and Forecast - IMARC Group
According to the latest report by IMARC Group, titled “Neurothrombectomy Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global neurothrombectomy devices market grew at a CAGR of around 6% during 2015-2020. Looking forward, IMARC Group expects the global neurothrombectomy devices market to exhibit moderate growth during 2021-2026. A neurothrombectomy is a process conducted using laser, mechanical, and ultrasound technologies to retrieve or destroy blood clots in the cerebral neurovasculature. It is primarily used for lowering the risk of hemorrhagic events, achieving recanalization, and increasing efficiency to treat large vessel occlusions. Neurothrombectomy devices also helps in reducing the mortality rate among patients and improving functional outcomes. Owing to these factors, neurothrombectomy devices find extensive application in treating acute ischemic stroke (AIS).
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request Free Sample Report: https://www.imarcgroup.com/neurothrombectomy-devices-market/requestsample
The growing utilization of neurothrombectomy devices to destroy blood clots and increase blood supply to the brain in order to treat strokes, dementia, depression, etc., is primarily driving the global market. Additionally, due to the faster product approval process, several key manufacturers are continuously introducing technologically advanced variants with improved efficiency, thereby further catalyzing the market growth. Numerous other factors, including the rising adoption of unhealthy lifestyles and increasing demand for marginally invasive surgeries by individuals, are expected to propel the global market for neurothrombectomy devices in the coming years.
Explore Full Report with TOC & List of Figure:https://www.imarcgroup.com/neurothrombectomy-devices-market
Key Market Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Acandis GmbH
- Argon Medical (Weigao Group)
- Edwards Lifesciences Corporation
- Johnson & Johnson
- Koninklijke Philips N.V.
- Medtronic Plc
- Penumbra Inc.
- Phenox GmbH
- Stryker Corporation
- Teleflex Incorporated
- Terumo Corporatio
- Vesalio LLC
Breakup by Product:
- Clot Retrievers
- Aspiration/Suction Devices
- Vascular Snares
Breakup by End Use:
- Hospitals and Clinics
- Ambulatory Surgical Centers
Breakup by Region:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
Key highlights of the Report:
- Market Performance
- Market Outlook
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Follow us on twitter: @imarcglobal